The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders

: Posttransplant lymphoproliferative disorders (PTLDs) are associated with significant morbidity and mortality among solid-organ transplant patients, but approaches to diagnosis and management vary considerably. An international multidisciplinary panel evaluated current understanding of risk factors...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation 2012-10, Vol.94 (8), p.784-793
Hauptverfasser: GLOTZ, Denis, CHAPMAN, Jeremy R, PASCUAL, Julio, RICKINSON, Alan B, RUSSO, Francesco P, TRAPPE, Ralf U, WEBSTER, Angela C, ZUCKERMANN, Andreas O, GROSS, Thomas G, DHARNIDHARKA, Vikas R, HANTO, Douglas W, CASTRO, Maria C. R, HIRSCH, Hans H, LEBLOND, Véronique, MEHTA, Aneesh K, MOULIN, Bruno, PAGLIUCA, Antonio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:: Posttransplant lymphoproliferative disorders (PTLDs) are associated with significant morbidity and mortality among solid-organ transplant patients, but approaches to diagnosis and management vary considerably. An international multidisciplinary panel evaluated current understanding of risk factors and classification systems and developed recommendations to aid in PTLD prevention. We considered evidence on PTLD risk factors including Epstein-Barr virus serostatus and immunosuppression and identified knowledge gaps for future research. Recommendations address prophylactic and preemptive strategies to minimize PTLD development, including modulation of immunosuppression and antiviral drug regimens. Finally, new classification criteria were outlined that may help facilitate standardized reporting and improve our understanding of PTLD.
ISSN:0041-1337
1534-6080
DOI:10.1097/TP.0b013e318269e64f